top of page

How Cambridge Innovation Capital has become a preeminent investment firm in Cambridge life sciences, and also a significant attractor of outside capital to Cambridge

CIC Partner Michael Anstey describes the firm's history and investment approach, lists some current investments, and offers advice for those who are interested in investing in Cambridge innovation.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page